Back to search

Article

Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network

2020-02-20

Abstract excerpt

<h4>ABSTRACT</h4> Mechanisms-of-resistance to decitabine and 5-azacytidine, mainstay treatments for myeloid malignancies, require investigation and countermeasures. Both are nucleoside analog pro-drugs processed by pyrimidine metabolism into a nucleotide analog that depletes the key epigenetic regulator DNA methyltranseferase 1 (DNMT1). We report here that DNMT1 protein, although substantially depleted (~50%) in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b12aa87b-c45c-5852-a08e-dbde61d77254
DOI
10.1101/2020.02.20.958405
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism networkDOI 10.1101/2020.02.20.958405
Select a neighboring publication to make it the new centre.